The landscape of m 1 A modification and its posttranscriptional regulatory functions in primary neurons
Cerebral ischaemia‒reperfusion injury (IRI), during which neurons undergo oxygen-glucose deprivation/reoxygenation (OGD/R), is a notable pathological process in many neurological diseases. N1-methyladenosine (m A) is an RNA modification that can affect gene expression and RNA stability. The m A land...
Gespeichert in:
Veröffentlicht in: | eLife 2023-03, Vol.12 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Cerebral ischaemia‒reperfusion injury (IRI), during which neurons undergo oxygen-glucose deprivation/reoxygenation (OGD/R), is a notable pathological process in many neurological diseases. N1-methyladenosine (m
A) is an RNA modification that can affect gene expression and RNA stability. The m
A landscape and potential functions of m
A modification in neurons remain poorly understood. We explored RNA (mRNA, lncRNA, and circRNA) m
A modification in normal and OGD/R-treated mouse neurons and the effect of m
A on diverse RNAs. We investigated the m
A landscape in primary neurons, identified m
A-modified RNAs, and found that OGD/R increased the number of m
A RNAs. m
A modification might also affect the regulatory mechanisms of noncoding RNAs, e.g., lncRNA-RNA binding proteins (RBPs) interactions and circRNA translation. We showed that m
A modification mediates the circRNA/lncRNA‒miRNA-mRNA competing endogenous RNA (ceRNA) mechanism and that 3' untranslated region (3'UTR) modification of mRNAs can hinder miRNA-mRNA binding. Three modification patterns were identified, and genes with different patterns had intrinsic mechanisms with potential m
A-regulatory specificity. Systematic analysis of the m
A landscape in normal and OGD/R neurons lays a critical foundation for understanding RNA modification and provides new perspectives and a theoretical basis for treating and developing drugs for OGD/R pathology-related diseases. |
---|---|
ISSN: | 2050-084X |
DOI: | 10.7554/eLife.85324 |